EXPERTLY EXECUTED PRECLINICAL ALS STUDIES
PharmaLegacy has the models and experience to drive your ALS pipeline forward.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR ALS PROGRAM.
MODELS / SERVICES
PharmaLegacy’s operational advantages:
- 1500+ validated animal models of disease spanning 100+ indications
- 30,000+ animal capacity
- Staffing and facilities to run 200+ concurrent studies
- 380,000 square feet of facilities
- Ability to start most studies in under 2 weeks
Advance your ALS pipelines with certainty and speed. Contact PharmaLegacy today.
We’re ready when you are.
Tell us your ALS pipeline challenges.
